Anne-Laure G.
- Country
- France
- Department
- Nuclear Medicine
Research Overview
- Evaluation of PSMA-Targeted Radionuclide Therapy in Adults with Metastatic Clear Cell Renal Cancer Post Anti-VEGFR and Immunotherapy Treatment
- Evaluation of Safety and Dosimetry of Lutetium (177Lu) Oxodotreotide in Adolescent Patients with SSTR-Positive GEP-NETs, Pheochromocytoma, and Paragangliomas
- Phase III Multicenter Trial Comparing Systematic Versus Serum Tg and RAI Scintigraphy-Guided Radioiodine Therapy in Intermediate-Risk Differentiated Thyroid Cancer
Data & Insights
Has run more than one trial at 23 of 53 partner sites.
Specializations
Endocrine Oncology
The investigator specializes in the treatment of differentiated thyroid cancer, with particular focus on intermediate-risk thyroid cancer patients. Their research explores optimization of radioiodine therapy protocols and post-operative treatment strategies.
- Thyroid Cancer Management
- Radioiodine Treatment Protocols
- Post-operative Assessment
Their work involves evaluation of serum biomarkers and diagnostic imaging for treatment decision-making.
Pediatric Oncology
The investigator focuses on treating refractory and recurrent neuroblastoma in pediatric patients. Their expertise includes the application of advanced peptide receptor radionuclide therapy using innovative radiopharmaceuticals.
- Neuroblastoma Treatment
- Pediatric Nuclear Medicine
- Targeted Radiotherapy
Their research encompasses novel therapeutic approaches for challenging pediatric cancer cases.
Nuclear Medicine
The investigator specializes in radionuclide therapy applications, particularly using Lu-177 labeled compounds. Their work integrates advanced nuclear medicine techniques for both adult and pediatric patients.
- Therapeutic Nuclear Medicine
- Radiopharmaceutical Applications
- Dosimetry Studies
Their expertise extends to the development and implementation of personalized radionuclide treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.